{"entity":{"type":"insider","cik":"0001738144","url":"/insider/0001738144","json_url":"/insider/0001738144.json","name":"Dorling Janet","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":7,"first":"2018-06-28","last":"2024-02-14","span_basis":"filed_date"},"name_variants":[{"name":"Dorling Janet","source":"filing","n_filings":7,"first_seen":"2018-06-28","last_seen":"2024-02-14"}],"transactions":[{"id":3153362,"accession":"0001062993-24-003202","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-24-003202","line_url":"/filing/0001062993-24-003202#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001738144","owner_name":"Dorling Janet","owner_display_name":"Dorling Janet","owner_url":"/insider/0001738144","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":31.9748,"price_display":"31.97","price_state":"stated","total_value":191848.8,"total_display":"191,848.80","total_whole":"191,849","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider"},{"id":2144667,"accession":"0001062993-24-000776","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-24-000776","line_url":"/filing/0001062993-24-000776#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001738144","owner_name":"Dorling Janet","owner_display_name":"Dorling Janet","owner_url":"/insider/0001738144","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":23.8574,"price_display":"23.86","price_state":"stated","total_value":143144.4,"total_display":"143,144.40","total_whole":"143,144","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-10","filed_date":"2024-01-10","scope":"insider"},{"id":8051466,"accession":"0001062993-23-022367","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-022367","line_url":"/filing/0001062993-23-022367#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001738144","owner_name":"Dorling Janet","owner_display_name":"Dorling Janet","owner_url":"/insider/0001738144","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6000.0,"shares_display":"6,000","price_per_share":20.0703,"price_display":"20.07","price_state":"stated","total_value":120421.8,"total_display":"120,421.80","total_whole":"120,422","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-11","scope":"insider"},{"id":7802840,"accession":"0001062993-23-020834","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-020834","line_url":"/filing/0001062993-23-020834#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001738144","owner_name":"Dorling Janet","owner_display_name":"Dorling Janet","owner_url":"/insider/0001738144","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7000.0,"shares_display":"7,000","price_per_share":15.2428,"price_display":"15.24","price_state":"stated","total_value":106699.6,"total_display":"106,699.60","total_whole":"106,700","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-10","filed_date":"2023-11-14","scope":"insider"},{"id":7868306,"accession":"0001567619-19-005389","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-005389","line_url":"/filing/0001567619-19-005389#line-1","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen, Inc.","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001738144","owner_name":"Dorling Janet","owner_display_name":"Dorling Janet","owner_url":"/insider/0001738144","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1063.0,"shares_display":"1,063","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":946.07,"total_display":"946.07","total_whole":"946","shares_owned_after":284738.0,"shares_owned_after_display":"284,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-21","filed_date":"2019-02-25","scope":"insider"},{"id":8191033,"accession":"0001567619-19-002682","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-19-002682","line_url":"/filing/0001567619-19-002682#line-1","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen, Inc.","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001738144","owner_name":"Dorling Janet","owner_display_name":"Dorling Janet","owner_url":"/insider/0001738144","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":818.0,"shares_display":"818","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":1104.3,"total_display":"1,104.30","total_whole":"1,104","shares_owned_after":285801.0,"shares_owned_after_display":"285,801","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-05","filed_date":"2019-02-07","scope":"insider"},{"id":6036064,"accession":"0001140361-18-030422","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-18-030422","line_url":"/filing/0001140361-18-030422#line-2","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen Inc","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":"0001738144","owner_name":"Dorling Janet","owner_display_name":"Dorling Janet","owner_url":"/insider/0001738144","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":450.0,"shares_display":"450","price_per_share":9.59,"price_display":"9.59","price_state":"stated","total_value":4315.5,"total_display":"4,315.50","total_whole":"4,316","shares_owned_after":23819.0,"shares_owned_after_display":"23,819","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-26","filed_date":"2018-06-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001042074","name":"CymaBay Therapeutics, Inc.","url":"/issuer/0001042074","role":"Director","n_filings":4,"first_seen":"2023-11-14","last_seen":"2024-02-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001301501","name":"Achaogen, Inc.","url":"/issuer/0001301501","role":"Officer (Chief Commercial Officer)","n_filings":3,"first_seen":"2018-06-28","last_seen":"2019-02-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001738144","retrieved_at":"2026-08-26T17:25:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}